What question did this study set out to answer?

The study aims to validate the TSO500 assay for genomic profiling of solid tumors and assess its clinical relevance in cancer management.

June 12, 2026Einstein (São Paulo)Open Access

Real-world genomic profiling of solid tumors: validation and clinical insights from a Brazilian cohort

View Full Paper

Ask AI

Bookmark

The study aims to validate the TSO500 assay for genomic profiling of solid tumors and assess its clinical relevance in cancer management.
Validation of the TSO500 assay in a CAP-accredited Brazilian laboratory.
Analysis of Comprehensive Genomic Profiling results from 454 patients with cancer.
Evaluation of analytical performance and identification of genomic alterations.
The TSO500 assay demonstrated high analytical performance.
Key genomic alterations, including novel fusions, were identified in the patient cohort.
Findings support the implementation of precision-guided cancer management strategies.

Implication

Randomized trial validates TSO500 assay for genomic profiling in cancer patients, suggesting precision-guided approaches.

Abstract

In BriefWe validated the TSO500 assay in a CAP-accredited Brazilian laboratory and analyzed the Comprehensive Genomic Profiling results from 454 patients with cancer.The TSO500 assay showed high analytical performance and revealed key genomic alterations, including novel fusions, supporting precision-guided cancer management.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Souza et al. (2026) studied this question.

synapsesocial.com/papers/6a2ba20e8101cf8926f01235 https://doi.org/10.31744/einstein_journal/2026ao2000

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial validates TSO500 assay for genomic profiling in cancer patients, suggesting precision-guided approaches.

Real-world genomic profiling of solid tumors: validation and clinical insights from a Brazilian cohort

Key Points

Implication

Abstract

Discussion

Cite This Study

Real-world genomic profiling of solid tumors: validation and clinical insights from a Brazilian cohort

Key Points

Implication

Abstract

Discussion

Cite This Study